$39.35
00.00%
At close: Jul 19, 5:08 PM EDT
$39.35
00.00%
After Hours: Jul 19, 5:08 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | GSK | GSK | FY | 2024 | $2.12 | $2.16 | $3.96 | $41.16B | $41.16B | $39.57B | Get Alert |
01/31/2024 | GSK | GSK | FY | 2024 | $1.64 | $1.69 | $4.05 | $39.53B | $40.29B | $39.82B | Get Alert |
11/01/2023 | GSK | GSK | FY | 2023 | $2.07 | $2.12 | $3.86 | $41.58B | $41.95B | $35.50B | Get Alert |
07/26/2023 | GSK | GSK | FY | 2023 | $1.99 | $2.05 | $3.80 | $39.63B | $40.37B | $37.43B | Get Alert |
04/26/2023 | GSK | GSK | FY | 2023 | $1.90 | $1.96 | $3.68 | $37.75B | $38.47B | $35.72B | Get Alert |
02/01/2023 | GSK | GSK | FY | 2023 | $1.94 | $1.99 | $3.64 | $38.54B | $39.27B | $35.92B | Get Alert |
11/02/2022 | GSK | GSK | FY | 2022 | — | — | — | $50.67B | $51.60B | $32.29B | Get Alert |
07/27/2022 | GSK | GSK | FY | 2022 | — | — | — | $49.73B | $50.67B | $38.72B | Get Alert |
10/27/2021 | GSK | GlaxoSmithKline | FY | 2021 | $1.56 | $1.59 | $2.86 | — | — | — | Get Alert |
07/29/2020 | GSK | GSK | FY | 2020 | $1.56 | $1.60 | $2.99 | — | — | — | Get Alert |
02/05/2020 | GSK | GSK | FY | 2020 | $1.56 | $1.60 | $3.06 | — | — | — | Get Alert |
The last reported Earnings numbers were from May 1, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $2.12 and $2.16 versus the estimated EPS of $3.96.
Browse guidance and forecast on all stocks.